Publications
Detailed Information
Feasibility of a slower lamotrigine titration schedule for bipolar depression: a naturalistic study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Joe, Soo Hyun | - |
dc.contributor.author | Chang, Jae Seung | - |
dc.contributor.author | Won, Seunghee | - |
dc.contributor.author | Rim, Hyo-Deog | - |
dc.contributor.author | Ha, Kyooseob | - |
dc.contributor.author | Ha, Tae Hyon | - |
dc.date.accessioned | 2012-07-05T01:40:02Z | - |
dc.date.available | 2012-07-05T01:40:02Z | - |
dc.date.issued | 2009-03 | - |
dc.identifier.citation | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY; Vol.24(2); 105-110 | ko_KR |
dc.identifier.issn | 0268-1315 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78547 | - |
dc.description.abstract | The development of a skin rash is often associated with a rapid escalation of lamotrigine dose. We used lamotrigine to treat 259 patients with Diagnostic and Statistical Manual of Mental Disorders, 4th edition, bipolar depression using either the standard titration schedule (n=132) or a slower titration schedule (n=127) and compared the clinical efficacy and safety of both groups. Clinical efficacy of lamotrigine treatment was assessed using changes in the Clinical Global Impression Scale for Bipolar Disorder-Modified scores during the course of the 12-week treatment A significant reduction of the Clinical Global Impression Scale for Bipolar Disorder-Modified score was observed in both groups and the effect size was large for both groups (standard, 0.75; slower, 0.71). A mixed-effect model of repeated measurement. revealed an increased rate of improvement in the standard titration group that was significant during the first 5 weeks (P<0.001) but became nonsignificant by the final 7 weeks of treatment. The statistically significant reduction in the development of rashes (P=0.005) was a major advantage for patients in the slower titration group. Although the standard titration schedule generally led to faster recovery from depressive symptoms, the slower titration schedule may be an option for patients with a high risk of rash development. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | ko_KR |
dc.subject | bipolar depression | ko_KR |
dc.subject | lamotrigine | ko_KR |
dc.subject | slower titration | ko_KR |
dc.title | Feasibility of a slower lamotrigine titration schedule for bipolar depression: a naturalistic study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 조수현 | - |
dc.contributor.AlternativeAuthor | 장재승 | - |
dc.contributor.AlternativeAuthor | 원승희 | - |
dc.contributor.AlternativeAuthor | 임효덕 | - |
dc.contributor.AlternativeAuthor | 하태현 | - |
dc.contributor.AlternativeAuthor | 하규섭 | - |
dc.identifier.doi | 10.1097/YIC.0b013e32832775fe | - |
dc.citation.journaltitle | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | - |
dc.description.citedreference | Ketter TA, 2008, J PSYCHIATR RES, V43, P13, DOI 10.1016/j.jpsychires.2008.02.007 | - |
dc.description.citedreference | Calabrese JR, 2008, BIPOLAR DISORD, V10, P323 | - |
dc.description.citedreference | Alvestad S, 2007, EPILEPSIA, V48, P1360, DOI 10.1111/j.1528-1167.2007.01109.x | - |
dc.description.citedreference | Keck PE, 2007, CNS SPECTRUMS, V12, P1 | - |
dc.description.citedreference | Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x | - |
dc.description.citedreference | Hirsch LJ, 2006, EPILEPSIA, V47, P318 | - |
dc.description.citedreference | Ostacher MJ, 2006, J CLIN PSYCHIAT, V67, P18 | - |
dc.description.citedreference | *GLAXOSMITHKLINE, 2006, PRESCR INF LAM LAM T | - |
dc.description.citedreference | Ketter TA, 2005, J CLIN PSYCHIAT, V66, P642 | - |
dc.description.citedreference | P-Codrea S, 2005, ACTA NEUROL SCAND, V111, P191, DOI 10.1111/j.1600-0404.2005.00381.x | - |
dc.description.citedreference | Silverstone PH, 2004, INT CLIN PSYCHOPHARM, V19, P113, DOI 10.1091/01.yic.0000125754.83499.55 | - |
dc.description.citedreference | Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a | - |
dc.description.citedreference | Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310 | - |
dc.description.citedreference | Katz MM, 2004, NEUROPSYCHOPHARMACOL, V29, P566, DOI 10.1038/sj.npp.1300341 | - |
dc.description.citedreference | Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432 | - |
dc.description.citedreference | Calabrese JR, 2003, J CLIN PSYCHIAT, V64, P1013 | - |
dc.description.citedreference | Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392 | - |
dc.description.citedreference | Choi H, 2003, EXPERT OPIN PHARMACO, V4, P243 | - |
dc.description.citedreference | Calabrese JR, 2002, J CLIN PSYCHIAT, V63, P1012 | - |
dc.description.citedreference | Calabrese JR, 2002, J CLIN PSYCHIAT, V63, P18 | - |
dc.description.citedreference | Frye MA, 2000, J CLIN PSYCHOPHARM, V20, P607 | - |
dc.description.citedreference | Rzany B, 1999, LANCET, V353, P2190 | - |
dc.description.citedreference | Calabrese JR, 1999, J CLIN PSYCHIAT, V60, P79 | - |
dc.description.citedreference | Messenheimer JA, 1998, CAN J NEUROL SCI, V25, pS14 | - |
dc.description.citedreference | Spearing MK, 1997, PSYCHIAT RES, V73, P159 | - |
dc.description.citedreference | COHEN J, 1988, STAT POWER ANAL BEHA | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.